By: Chirag Shah; Shereta Wiley; Sylvie Stacy; Leslie Lundt In a poster session, researchers sought to understand the evolving continuing medical education (CME) needs of psychiatrists managing patients with tardive dyskinesia...
Read MoreAs an involuntary movement disorder resulting from exposure to dopamine antagonists, tardive dyskinesia (TD) classically manifests as involuntary oro-bucco-lingual and facial dyskinesia, as well as limb, trunk, and respiratory...
Read MoreThere is growing number of treatment-refractory patients in psychiatric practice. Although evidence-based treatments may be effective in most patients, there is a significant number of psychiatric patients, who may not have an...
Read MoreData from the real-world RE-KINECT study were analyzed to better understand the impact of tardive dyskinesia (TD) on wellbeing and health state in patients who are aware of their TD. Over 200 adults with over 3 months of...
Read More
This Year’s Theme: Finding Equity Through Advances in Mind & Brain in Unsettled Times...
Read MoreA year since COVID-19 was declared a worldwide emergency, experts warn that a subsequent mental health pandemic is imminent, due to the lasting adverse impacts of stress, anxiety and isolation. This year’s Annual Meeting offers...
Read MoreFriday, April 30, 2021 11:00 a.m. – 5:30 p.m. ET Pre-Conference Expo Virtual Exhibit Gallery Product Theater Showcases Saturday, May 1, 2021 10:00 a.m. – 11:00 a.m. ET Opening Session (Plenary), Featuring Keynote Speaker Isabel...
Read MoreSchedule Friday, April 30, 2021 Noon – 1:00 p.m. ET Supported by Axsome Therapeutics Inc. [Product Theater 1] New Pathways in Depression: Potential to Improve Clinical Outcomes Roger S. McIntyre MD, FRCP Professor of...
Read MoreAPA is pleased to announce that Anthony Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases will deliver the 2021 William C. Menninger Memorial Convocation Lecture on May 2. At NIAID, Fauci...
Read MoreProf. Tony Traboulsee talks to Physician’s Weekly about his study of tolebrutinib Presented at the American Academy of Neurology (AAN) 2021 Annual Meeting, Anthony Traboulsee, MD, professor and research chair of the MS Society...
Read MoreRecommendations still oppose pregnancy during MS therapy Women with relapsing multiple sclerosis (RMS) who became pregnant while undergoing treatment with ozanimod—an oral sphingosine 1-phosphate (S1P) receptor...
Read MoreReduction in lesion activity seen as early as 8 weeks Patients diagnosed with relapsing multiple sclerosis begin to get relief from radiological symptoms as early as the first visit to the clinic after being prescribed...
Read MoreAlthough the CheckMate-9ER trial, comparing cabozantinib plus nivolumab to sunitinib in frontline metastatic renal cell carcinoma (mRCC), had recently demonstrated improved progression-free survival (PFS) and overall survival...
Read More
Patients with hidradenitis suppurativa were asked about their satisfaction regarding telemedicine...
Read More
First author: Niki Nourmohammadi The COVID-19 pandemic has been associated with psychological...
Read More
Presented by: Prof. Mario Lacouture, Memorial Sloan Kettering Cancer Centre As advances in breast...
Read More
A side effect that might not be the first to think about in the COVID-19 pandemic concerns wearing...
Read More
Presented by: Jules Lipoff (University of Pennsylvania), Elizabeth Jones (Thomas Jefferson...
Read More
The importance of sunscreen has been acknowledged globally. Recent topics of discussion include...
Read More
